MEASUREMENT OF CYCLOSPORINE-A BY A SPECIFIC RADIOIMMUNOASSAY WITH A MONOCLONAL-ANTIBODY AND I-125 TRACER

被引:15
作者
LEE, SC
BRUDZINSKI, AM
YASMINEH, JL
JOHANSON, NJ
FERBER, IA
MAAS, LK
WONG, PY
KEOWN, PA
ORF, JW
机构
[1] TORONTO GEN HOSP,TORONTO M5G 1L7,ONTARIO,CANADA
[2] BRITISH COLUMBIA TRANSPLANT SOC,VANCOUVER,BC,CANADA
关键词
CYCLOSPORINE-A; DRUG MONITORING; RADIOIMMUNOASSAY; TRANSPLANTATION; MONOCLONAL ANTIBODY;
D O I
10.1016/0009-9120(91)90168-E
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a sensitive radioimmunoassay (CYCLO-Trac(R) SP) that specifically measures cyclosporine A in serum, plasma and whole blood of transplant patients. The specific monoclonal antibody was from Sandoz and the tracer was an I-125 derivative of cyclosporine C. The assay is performed at room temperature for 1 h followed by a 20 min centrifugation. The sensitivities of the assays are 2.6 ng/mL and 8.7 ng/mL for the serum/plasma assay and the whole blood assay, respectively. Within-run and between-run CVs for both types of assays using cyclosporine concentrations of 80 and 58 ng/mL (serum) and 186 and 199 ng/mL (whole blood) were less than 5% and 9%, respectively. Averaged recovery of serum/plasma and whole blood assays at various levels ranged from 93% to 115%. Interferences by bilirubin, triglyceride, cholesterol, hemoglobin, OKT-3, azathioprine, methylprednisolone and 20 other drugs were insignificant. Multicenter proficiency studies showed an excellent correlation between the CYCLO-Trac(R) SP and the specific H-3-Sandimmune(R) assay from Sandoz: whole blood assay (r = 0.998) and serum assay (r = 0.997).
引用
收藏
页码:43 / 48
页数:6
相关论文
共 29 条
[21]  
ROSANO TG, 1986, TRANSPLANT P, V18, P35
[22]  
SCHRAN HF, 1987, CLIN CHEM, V33, P2225
[23]   COMPARISON OF SPECIFIC RADIOIMMUNOASSAYS FOR CYCLOSPORINE [J].
SGOUTAS, DS ;
HAMMARSTROM, M .
TRANSPLANTATION, 1989, 47 (04) :668-670
[24]  
SHAW LM, 1987, CLIN CHEM, V33, P1269
[25]   CYCLOSPORINE - STRUCTURE, PHARMACOKINETICS, AND THERAPEUTIC DRUG-MONITORING [J].
VINE, W ;
BOWERS, LD .
CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (04) :275-311
[26]  
WALLEMACQ PE, 1990, CLIN CHEM, V36, P385
[27]  
WOLF BA, 1989, CLIN CHEM, V35, P120
[28]  
WONG PY, 1986, CLIN CHEM, V32, P492
[29]  
YATSCOFF RW, 1984, CLIN CHEM, V30, P1812